Dentsu Group Inc. (4324.T) Bundle
Investors parsing Dentsu Group Inc.'s latest results should note the stark contrasts in the company's performance: FY2024 net revenues of 1,421,000 million yen represented a 5.7% year-on-year rise despite organic growth of -0.1%, while Q4 showed sequential improvement with 2.6% organic growth and Japan delivering roughly 4% organic growth as international markets lagged (Americas -3.4%, EMEA -2.4% in H1 2025); however, FY2024 also carried a net loss of 192.2 billion yen driven by a 210.1 billion yen goodwill impairment in Q4, a statutory operating loss of 125.0 billion yen, and a revised FY2025 revenue guidance trimmed to 1,421,000 million yen from 1,433,200 million yen; management is targeting 52 billion yen in annual cost savings and a headcount reduction of approximately 3,400 to shore up finances, with underlying operating profit for FY2025 projected at 161.2 billion yen (about a 13% margin) even as the company predicts a FY2025 net loss of 52.9 billion yen, suspends the interim dividend, and holds capital of 74,609.81 million yen as it pursues its Mid-Term Management Plan and strategic options for underperforming international businesses.
Dentsu Group Inc. (4324.T) Revenue Analysis
Dentsu Group Inc. reported net revenues of 1,421,000 million yen for FY2024, up 5.7% year-on-year, while organic growth was essentially flat at -0.1%. The fourth quarter showed a sequential improvement with 2.6% organic growth, driven by stronger performance in Japan versus weakness internationally.- FY2024 net revenues: 1,421,000 million yen (+5.7% YoY)
- FY2024 organic growth: -0.1%
- Q4 organic growth: +2.6% (sequential improvement)
- Net loss FY2024: -192,200 million yen (driven by goodwill impairment)
- Goodwill impairment (Q4 FY2024): 210,100 million yen
- Japan segment: ~4% organic growth (outperformed)
- International business: ~-3% organic growth (declined)
- Americas (H1 2025): -3.4% organic growth
- EMEA (H1 2025): -2.4% organic growth
- Russia disposal (July 2024): reduced Q1 2025 net revenue by ~0.6%
| Metric | Value | Notes |
|---|---|---|
| Net revenue (FY2024) | 1,421,000 million yen | Reported (+5.7% YoY) |
| Organic growth (FY2024) | -0.1% | Flat excluding M&A and FX |
| Q4 organic growth | +2.6% | Sequential improvement |
| Japan organic growth | ~4.0% | Outperformed other regions |
| International organic growth | ~-3.0% | Includes Americas & EMEA weakness |
| Americas (H1 2025) organic growth | -3.4% | Soft demand |
| EMEA (H1 2025) organic growth | -2.4% | Weak performance |
| Net loss (FY2024) | -192,200 million yen | Primarily goodwill impairment |
| Goodwill impairment (Q4 FY2024) | 210,100 million yen | Major one-off charge |
| Russia business sale impact (Q1 2025) | -0.6% net revenue | Sale completed July 2024 |
| Revised FY2025 revenue guidance | 1,421,000 million yen | Down from prior 1,433,200 million yen forecast |
- Top-line growth (+5.7% reported) masks near-zero organic growth (-0.1%) and regional divergence.
- Japan is the primary growth driver; Americas and EMEA remain pressured.
- Significant Q4 goodwill impairment (210.1 billion yen) created a statutory net loss despite operational revenue gains.
- Revised FY2025 guidance at 1,421,000 million yen signals a more cautious outlook versus prior 1,433,200 million yen forecast.
Dentsu Group Inc. (4324.T) - Profitability Metrics
Dentsu Group's profitability profile over recent fiscal years reflects a mix of operational recovery and one-off impairment impacts.- Operating margin (FY2024): 14.8% - a 30 basis point improvement year-on-year; Q4 margin supported by stronger-than-expected Japan performance.
- Statutory operating result (FY2024): operating loss of ¥125.0 billion, driven by goodwill impairment losses.
- Underlying operating profit (FY2025 guidance): ¥161.2 billion, implying an operating margin of ~13% on management's projection.
- Q1 FY2025: operating profit rose 75.5% to ¥25,426 million despite a slight decrease in net revenue.
- Net profit attributable to owners (FY2025): loss of ¥52.9 billion, an improvement versus prior company forecast of a ¥75.4 billion loss.
- Dividends: interim dividend suspended; year‑end dividend left undetermined due to impairment and reduced retained earnings.
| Metric | FY2023 | FY2024 (Reported) | FY2025 (Management Guidance / Q1) |
|---|---|---|---|
| Operating margin | N/A | 14.8% (+30 bp YoY) | ~13.0% (guidance) |
| Statutory operating result | N/A | Operating loss ¥125.0 bn (goodwill impairment) | Underlying operating profit ¥161.2 bn (guidance) |
| Underlying / Adjusted operating profit | N/A | N/A | ¥161.2 bn |
| Q1 FY2025 operating profit | N/A | N/A | ¥25,426 million (up 75.5% YoY) |
| Net profit attributable to owners | N/A | N/A | Loss ¥52.9 bn (improved vs prior forecast loss ¥75.4 bn) |
| Dividends | N/A | Interim suspended; year‑end undetermined | Interim suspended; year‑end undetermined |
Dentsu Group Inc. (4324.T) - Debt vs. Equity Structure
While granular line-by-line debt and equity figures are not publicly disclosed in available sources, the balance between leverage and shareholders' capital at Dentsu Group Inc. (4324.T) has been materially affected by recent impairments, restructuring and ongoing operational challenges. Key items that shape the group's capital structure and investor considerations are listed below.- Goodwill impairment: 210.1 billion yen charge in FY2024, materially reducing equity.
- Revised FY2025 full-year net loss forecast: 52.9 billion yen, reflecting continued international segment weakness.
- Cost reduction program: targeted annual savings of 52 billion yen and ~3,400 international headcount reductions.
- Capital (shareholders' equity / stated capital basis) reported as of April 28, 2025: 74,609.81 million yen.
- Dividend policy: interim dividend suspended; year-end dividend undetermined, signaling conservatism on shareholder distributions while restructuring proceeds.
| Metric | Amount (JPY) | Notes |
|---|---|---|
| Goodwill impairment (FY2024) | 210,100,000,000 | Non-cash charge that reduced equity significantly |
| FY2025 revised net loss forecast | 52,900,000,000 | Company guidance reflecting international business headwinds |
| Targeted annual cost savings | 52,000,000,000 | Ongoing restructuring initiative |
| Targeted headcount reduction | ≈3,400 employees | Primarily international workforce adjustments |
| Capital (as of 28 Apr 2025) | 74,609,810,000 | Reported company capital figure |
| Dividend status | Interim suspended / Year-end undetermined | Conservative cash allocation amid restructuring |
- Equity base pressure: the 210.1 billion yen goodwill write-down directly reduced shareholders' equity, increasing leverage ratios if debt levels remain unchanged.
- Profitability and cashflow risk: the forecasted 52.9 billion yen net loss for FY2025 implies continued negative earnings, potentially constraining retained earnings rebuild and raising reliance on existing liquidity or refinancing.
- Cost and headcount actions (52 billion yen savings; ~3,400 roles) aim to restore margins and free cash flow to stabilize capital structure.
- Dividend suspension reduces near-term cash outflows to preserve capital and service obligations during restructuring.
Dentsu Group Inc. (4324.T) - Liquidity and Solvency
Dentsu Group Inc. has not publicly disclosed detailed liquidity ratios or standard solvency metrics in available filings, but several material items and management actions provide insight into its near-term liquidity and balance-sheet resilience.
- Goodwill impairment loss: ¥210.1 billion recorded in FY2024, a significant non-cash charge that reduces equity and impacts solvency metrics (book value of equity).
- Projected net loss for FY2025: ¥52.9 billion, which, if realized, will further pressure retained earnings and equity headroom.
- Cost-reduction initiatives: headcount reduction of approximately 3,400 employees aimed at lowering fixed costs and preserving cash flow.
- Dividends: interim dividend suspended and year-end dividend undecided - a clear management preference to conserve cash.
- Profit recovery target: revised full-year FY2025 operating profit forecast of ¥17.6 billion, indicating steps to return to profitability and improve operating cash generation.
- Capital buffer: paid-in capital as of April 28, 2025 reported at ¥74,609.81 million, providing some capital buffer against losses.
| Metric | Value | Period / Note |
|---|---|---|
| Goodwill impairment | ¥210.1 billion | FY2024 (non-cash) |
| Projected net loss | ¥52.9 billion | FY2025 (management projection) |
| Revised operating profit forecast | ¥17.6 billion | Full-year FY2025 |
| Headcount reduction | ≈3,400 employees | Cost-reduction measure |
| Dividends | Interim suspended; year-end undecided | Cash preservation |
| Capital (paid-in) | ¥74,609.81 million | As of April 28, 2025 |
- Liquidity implications: suspension of dividends and headcount reductions free near-term cash; however, the combination of a very large goodwill write-down and projected operating loss weakens equity cushions and could constrain ability to raise unsecured financing without remedial actions.
- Solvency implications: the ¥210.1bn impairment materially reduces book equity and may deteriorate leverage ratios; the planned return to operating profit (¥17.6bn forecast) is a necessary step to rebuild solvency over time.
- Key monitoring items for investors:
- Actual FY2025 net result versus projected ¥52.9bn loss.
- Cash-flow from operations trajectory as cost cuts take effect.
- Any additional asset writedowns or restructuring costs.
- Decisions on year-end dividend or other cash-return policies.
Context on strategy and company background: Dentsu Group Inc.: History, Ownership, Mission, How It Works & Makes Money
Dentsu Group Inc. (4324.T) - Valuation Analysis
The following analysis highlights the valuation-relevant facts and observable drivers affecting Dentsu Group Inc.'s market assessment given the information available.
- Specific valuation metrics (e.g., P/E ratio, consensus market capitalization) are not available from the provided sources.
- Stock performance has been materially influenced by recent financial challenges, notably a recorded goodwill impairment loss and reported net losses.
- Analyst ratings and price targets are not provided in the available information.
- The company suspended its interim dividend and has not determined a year‑end dividend, which can weigh on investor sentiment and perceived equity value.
- Reported capital as of April 28, 2025: 74,609.81 million yen - a balance-sheet figure that factors into book-value-based valuation approaches.
- Management revised the full-year 2025 net loss forecast to a loss of 52.9 billion yen, a direct negative input to earnings-based multiples and forward-looking valuation models.
| Metric | Value / Note |
|---|---|
| Capital (as of 2025-04-28) | 74,609.81 million yen |
| Revised Full‑Year 2025 Net Loss Forecast | Loss of 52.9 billion yen |
| Goodwill Impairment | Recognized (amount not specified in provided sources) |
| Interim Dividend | Suspended |
| Year‑End Dividend | Undetermined |
| P/E Ratio / Market Cap / Analyst Targets | Not available from provided information |
- Valuation implications:
- Large net loss forecasts (¥52.9bn) compress forward earnings multiples and make P/E unreliable or negative.
- Goodwill impairment reduces equity and can pressure price-to-book ratios; it also signals past overpayment risk which may lower investor confidence.
- Dividend suspension reduces shareholder income expectations and can negatively affect yield-based valuation comparisons.
- Capital of ¥74,609.81m provides a tangible equity base for book-value assessments, but recent losses and impairments require careful adjustment of book value for meaningful comparisons.
- Data gaps to resolve for full valuation:
- Current market capitalization and share count to compute market-to-book and enterprise value metrics.
- Quantified amount of the goodwill impairment and historical EBITDA to derive adjusted multiples.
- Analyst consensus forecasts and price targets to gauge market expectations.
For broader corporate context and how Dentsu generates revenue, see: Dentsu Group Inc.: History, Ownership, Mission, How It Works & Makes Money
Dentsu Group Inc. (4324.T) - Risk Factors
The following risk factors are material to Dentsu Group Inc. (4324.T) investors and reflect recent operational and financial developments that may influence near- to medium-term performance.- Weakness in international organic growth: In H1 FY2025 organic growth rates were negative in key regions - Americas: -3.4%; EMEA: -2.4% - indicating demand pressure in major markets and potential margin compression.
- Large non-cash impairment and projected operating losses: The company recorded a goodwill impairment loss of ¥210.1 billion in FY2024 and is forecasting a net loss of ¥52.9 billion for FY2025, signaling significant balance-sheet write-downs and recurring profitability risk.
- Dividend uncertainty and shareholder confidence: The interim dividend has been suspended and the year-end dividend remains undetermined, which can erode investor confidence and reduce income-oriented investor appeal.
- Restructuring and workforce reductions: Cost-reduction measures include a headcount reduction of ~3,400 employees; while aimed at restoring profitability, these actions may harm operational capacity, client service levels and employee morale.
- Portfolio and geographic shifts: The sale of the Russia business in July 2024 reduces exposure to a sanctioned/volatile market but also removes a revenue stream and may create one-off and ongoing strategic implications for regional service delivery.
- Capital base and financial flexibility: As of April 28, 2025, the company's capital stood at ¥74,609.81 million, which affects its ability to absorb shocks, fund transformation initiatives, and service debt or working capital needs.
| Metric | Value | Period / Note |
|---|---|---|
| Americas organic growth | -3.4% | H1 FY2025 |
| EMEA organic growth | -2.4% | H1 FY2025 |
| Goodwill impairment loss | ¥210.1 billion | FY2024 |
| Projected net income (loss) | ¥-52.9 billion | FY2025 forecast |
| Interim dividend | Suspended | Declared FY2025 interim |
| Year-end dividend | Undetermined | FY2025 |
| Headcount reduction | ~3,400 employees | Cost-reduction program |
| Sale of Russia business | Completed July 2024 | Strategic/portfolio change |
| Capital | ¥74,609.81 million | As of April 28, 2025 |
Dentsu Group Inc. (4324.T) - Growth Opportunities
Dentsu Group Inc. (4324.T) enters FY2025 with several actionable growth vectors anchored by a resilient Japan business and an explicit corporate pivot under its Mid-Term Management Plan (2025-2027). The company's Japan segment reported an organic growth rate of approximately 4% in FY2025, signaling an ability to expand core operations domestically even as international segments undergo review.- Japan core strength: organic growth ≈ 4% in FY2025, driving stable top-line momentum and margin support.
- Capital base: paid-in capital of 74,609.81 million yen (as of April 28, 2025) that can be deployed to fund strategic investments, M&A, or restructuring costs.
- Mid-Term Management Plan (2025-2027): clear objective to realign the business portfolio, reprioritize capital allocation and regain competitiveness.
- Portfolio realignment - reallocate resources toward higher-growth units and streamline underperforming operations.
- Strategic partnerships and restructuring - exploring JV, minority investment, divestiture or operational carve-outs for international underperformers to accelerate returns.
- ESG and resilience integration - embedding environmental risk/opportunity assessment into strategy to capture sustainability-driven demand and client budgets.
- Governance and culture initiatives - strengthening integrity, accountability and talent retention to improve execution and operational efficiency.
| Metric | Value / Status | Implication for Growth |
|---|---|---|
| Japan organic growth (FY2025) | ≈ 4% | Reliable domestic revenue base to fund transformation. |
| Paid-in capital (as of 2025-04-28) | 74,609.81 million JPY | Balance-sheet buffer for investments, restructuring and M&A. |
| Mid-Term Management Plan | 2025-2027 (portfolio realignment) | Roadmap to prioritize high-return initiatives and refocus resources. |
| International business stance | Underperformance review - partnerships/restructuring options being considered | Potential to unlock value via deals, carve-outs or strategic alliances. |
| ESG / Resilience focus | Integration into strategy and risk management | Opportunity to win sustainability-led client spend and mitigate transition risks. |
| Governance & culture emphasis | Programs to enhance integrity and execution | Improves operational performance and investor confidence. |
- Watch execution on the Mid-Term Plan (2025-2027): milestones for divestments, announced partnerships, and reallocated capex will be leading indicators of progress.
- Monitor Japan segment margins and client retention as the primary cash-generator while international actions unfold.
- Assess capital deployment: how much of the 74,609.81 million JPY base is earmarked for M&A, restructuring costs, dividend/shareholder returns or balance-sheet strengthening.
- Track ESG disclosures and external ratings-clear metrics and targets can translate into new client opportunities and reduce financing risk.

Dentsu Group Inc. (4324.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.